What a readmission is

A readmission is an unplanned admission to an inpatient hospital that follows a previous discharge within a defined window. The most common window is 30 days, which is what the CMS Hospital Readmissions Reduction Program (HRRP) and the NCQA HEDIS Plan All-Cause Readmissions (PCR) measure both use. Planned readmissions, such as a scheduled chemotherapy admission or a staged surgical procedure, are generally excluded so the measure isolates the avoidable returns.

The 30-day window matters because readmission risk is highest in the days right after discharge. A return that happens on day 3 usually reflects something that went wrong in the handoff, not a new and unrelated illness, which is why the post-discharge period is where teams concentrate their effort.

Why readmissions matter in value-based care

Readmissions are expensive and frequently avoidable, and in value-based care the risk-bearing organization carries that cost directly. According to CMS, a readmission within 30 days of discharge is frequently avoidable and can lead to worse patient outcomes and higher costs, and a high readmission rate may signal inadequate quality of care or a lack of post-discharge coordination.

The financial and quality consequences run on two tracks. HRRP reduces Medicare payments to hospitals whose readmission rates for specific conditions exceed expected levels. For health plans and the risk-bearing groups they delegate to, the HEDIS PCR measure scores risk-adjusted all-cause readmissions and feeds quality ratings. Either way, lowering avoidable readmissions protects both quality scores and the cost side of a risk contract.

How readmissions are measured

Two programs define how readmissions are tracked, and they apply to different parties:

  • CMS Hospital Readmissions Reduction Program (HRRP). A Medicare value-based purchasing program that penalizes hospitals with higher-than-expected 30-day readmission rates for a defined set of conditions. It is hospital-facing.
  • NCQA HEDIS Plan All-Cause Readmissions (PCR). A plan-level measure that scores the risk-adjusted rate of unplanned 30-day readmissions for any cause across a health plan's members. It is plan-facing and reported as a CMS Star Ratings measure.
  • Risk adjustment. Both approaches adjust for how sick the population is, so a plan or hospital serving a higher-acuity panel is not penalized simply for treating sicker patients. The comparison is against an expected rate, not a flat threshold.

The Medicare 30-day readmission rule

No statute is actually named the Medicare 30-day readmission rule. What people mean by it is the Hospital Readmissions Reduction Program, created by the Affordable Care Act and in force since October 1, 2012. HRRP compares each hospital's 30-day risk-standardized unplanned readmission rate against what CMS expects for a hospital treating that case mix, and cuts the following year's base operating DRG payments when the hospital does worse than expected.

  • Six conditions define the denominator. Heart attack (AMI), heart failure, pneumonia, chronic obstructive pulmonary disease, elective hip or knee replacement, and coronary artery bypass graft.
  • The 30-day window is all-cause. Once a stay for one of those conditions is in the denominator, any unplanned readmission inside 30 days counts, whatever the patient came back for. Planned readmissions are excluded.
  • The penalty caps at 3%. The ACA phased it in at 1% for FY2013 and 2% for FY2014, then 3% from FY2015 onward, where it has stayed. Most penalized hospitals land far below the cap; the median cut is under 1% of inpatient Medicare payments.

HRRP is hospital-facing, so a physician group or IPA never receives the penalty directly. It shapes behavior anyway, because the hospitals a group discharges into are working the same 30-day clock and will push for post-discharge follow-up they can see.

Plan All-Cause Readmissions (PCR)

Plan All-Cause Readmissions is the NCQA HEDIS measure that scores the plan rather than the hospital. It looks at acute inpatient and observation stays for members 18 and older, then reports unplanned readmissions within 30 days for any diagnosis as an observed-to-expected ratio: actual readmissions divided by what the risk model predicted for that population.

An O/E ratio below 1.0 means fewer readmissions than expected, and above 1.0 means more. The ratio form is what lets a plan with a sicker book be judged fairly, and it is also why a raw percentage from a hospital report is not comparable to a PCR result. PCR is reported across Medicare, Medicaid, and commercial lines and carries into Medicare Star Ratings, which is why plan quality teams and the delegated groups underneath them both watch it.

Two differences from HRRP are worth holding onto. PCR is all-cause across every admission type rather than six named conditions, and the accountable party is the plan or its delegated group, not the discharging hospital.

How readmission risk is scored

Knowing a patient was discharged is not the same as knowing who is likely to come back. Risk scores rank the discharge list so the scarce follow-up capacity goes where it changes the outcome. Two validated scores show up most often.

The LACE index

LACE is the score most care management teams meet first, because it runs on four inputs a discharge record already has:

  • L, length of stay. Days in the index admission.
  • A, acuity of admission. Whether the patient was admitted through the emergency department.
  • C, comorbidity. The Charlson comorbidity index for the patient.
  • E, emergency department visits. The count of ED visits in the six months before the admission.

The total runs from 0 to 19. The standard bands are 0 to 4 for low risk, 5 to 9 for moderate, and 10 or higher for high risk, and 10 is the threshold most programs use to trigger intensive follow-up. LACE is popular because it is simple enough to compute at the bedside, not because it is the most accurate model available.

The HOSPITAL score

The HOSPITAL score predicts something narrower and more useful: readmissions that were potentially avoidable. It uses seven variables available at discharge, including hemoglobin and sodium levels, discharge from an oncology service, whether a procedure was performed during the stay, an urgent index admission, admissions in the prior 12 months, and a length of stay of five days or more. It has been validated across roughly 117,000 patients at nine hospitals in four countries, with a c-statistic around 0.72, and has outperformed LACE in head-to-head studies.

Most health systems now run an EHR-native model instead of either one, and the scores tend to converge on the same patients: long stay, frequent recent utilization, heavy comorbidity burden. The operational bottleneck is rarely the model. It is whether the discharge reaches the care team in time for the score to matter.

How transitions-of-care follow-up reduces readmissions

Most avoidable readmissions come from a failed handoff: medications never reconciled, a warning sign nobody caught, or a follow-up visit that was never scheduled. Timely transitions-of-care follow-up is the intervention that catches these problems while they are still manageable.

  • The discharge has to be known in real time. An ADT discharge event is the first signal a care team gets, and acting on it is what makes the rest of the follow-up possible.
  • Early contact catches problems early. An interactive contact within 2 business days of discharge, the same window transitional care management requires, surfaces medication confusion and missed appointments before they escalate.
  • A fast follow-up visit prevents the return. Scheduling a follow-up visit within 7 days of discharge is one of the most effective ways to prevent a readmission.

Common mistakes teams make with readmissions

  • Learning about the discharge too late. Without a real-time ADT feed, the team finds out a patient went home days later, after the highest-risk window has already passed.
  • Treating all discharges the same. A patient with multiple high-risk chronic conditions needs faster, closer follow-up than a routine discharge. Flat workflows spread effort evenly when risk is not even.
  • Confusing the hospital measure with the plan measure. HRRP and PCR are different programs with different denominators. Optimizing for one does not automatically move the other.
  • Counting outreach instead of outcomes. A reminder call that does not result in medication reconciliation or a completed visit does not lower readmission risk. The follow-up has to close the loop, not just touch the patient.
  • Duplicate outreach across silos. When quality, care management, and risk teams each work the same discharge separately, the patient gets repeat calls and the team wastes capacity that should go to the next discharge.

How Pelica handles readmissions

Pelica's Care Management Copilot ingests ADT discharge events in real time, builds the transitions-of-care worklist, tracks the 5-day follow-up window so the early contact and the visit both happen on time, and routes everything through one outreach queue so teams are not calling the same patient twice. Across Pelica deployments, customers close 70%+ of TRC gaps within 30 days and reach a 75% follow-up rate on the FMC 7-day measure.

Related terms

Readmission is the outcome the transitions-of-care cluster works to prevent. ADT (Admit, Discharge, Transfer) is the real-time event that starts the follow-up clock. TCM (Transitional Care Management) is the Medicare service, with its 2-business-day contact and 7-to-14-day visit, that operationalizes the prevention.

Sources